The subject invention relates in part to stacking certain Cry genes along with Cry1Fa to result in products that are more durable and less prone towards insects developing resistance towards the activity of any of the toxins (such as Cry1Fa) by itself. Embodiments of the Cry1F stacking partners include Cry2Aa, Cry1I, and Cry1E. These stacks can be used to control FAW and/or ECB as described herein.
展开▼